Standardization of the dot enzyme-linked immunosorbent assay (dot-ELISA) for experimental plague. 1993

S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
Centro de Pesquisas Aggeu Magalhães-FIOCRUZ, Recife, PE, Brasil.

A dot enzyme linked immunosorbent assay (dot-ELISA) was previously developed to detect specific antibodies in rabbits sera immunized against F1A protein obtained from Yersinia pestis. This antigen was covalently linked onto the surface of dacron (polyethyleneterephthalate). Here, standard conditions are described for the optimization of this procedure: an amount of 20 ng of F1A protein was fixed onto dacron; anti-rabbit IgG peroxidase conjugate diluted 1:8,000 and 30% non-fat instant milk as blocking substance were used throughout the method. This procedure was compared with that employing nitrocellulose as solid-phase which showed to be more sensitive. However, the method based on dacron did not show false positive reactions against non-immunized rabbits sera at low antigen amount and diluted anti-IgG peroxidase conjugate.

UI MeSH Term Description Entries
D010930 Plague An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form. Bubonic Plague,Meningeal Plague,Pneumonic Plague,Pulmonic Plague,Black Death,Black Plague,Septicemic Plague,Yersinia pestis Infection
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D015010 Yersinia pestis The etiologic agent of PLAGUE in man, rats, ground squirrels, and other rodents. Bacillus pestis,Bacterium pestis,Pasteurella pestis,Pestisella pestis,Yersinia pseudotuberculosis subsp. pestis
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings

Related Publications

S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
November 1984, The American journal of tropical medicine and hygiene,
S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
December 1989, Journal of the Egyptian Society of Parasitology,
S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
October 1988, Laboratory animal science,
S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
August 1989, The Journal of parasitology,
S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
January 1991, Revista do Instituto de Medicina Tropical de Sao Paulo,
S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
January 1997, Revista do Instituto de Medicina Tropical de Sao Paulo,
S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
August 1988, Annals of tropical medicine and parasitology,
S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
March 1999, Contemporary topics in laboratory animal science,
S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
January 1994, Methods in molecular biology (Clifton, N.J.),
S M Montenegro, and A M De Almeida, and L B Carvalho Júnior
December 1978, Hospital practice,
Copied contents to your clipboard!